The application of modified flow-through cell apparatus for the assessment of chlorhexidine dihydrochloride release from lozenges containing sorbitol

AAPS PharmSciTech

Volumn 10, Issue 3, 2009, Pages 1048-1057

  Musial, Witold ^a   Mielck, Jobst B ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Chlorhexidine; Lactose; Lozenges; Magnesium stearate; Release rate; Sorbitol

Indexed keywords

CHLORHEXIDINE; EXCIPIENT; LACTOSE; MAGNESIUM STEARATE; SORBITOL;

ARTICLE; CALCULATION; DRUG FORMULATION; DRUG GRANULATION; DRUG RELEASE; DRUG SOLUBILITY; LOZENGE; TABLET DISINTEGRATION; THRUSH;

CANDIDIASIS; CHEMISTRY, PHARMACEUTICAL; CHLORHEXIDINE; DENTAL CARIES; DENTAL PLAQUE; DISINFECTANTS; DRUG COMPOUNDING; HARDNESS; KINETICS; PHARMACEUTIC AIDS; POWDERS; SOLUBILITY; SORBITOL; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 70449533074     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9298-y     Document Type: Article

References (27)

1. P Gjermo 1974 Chlorhexidine in dental practice J Clin Periodontol. 1 143 152 4217806 10.1111/j.1600-051X.1974.tb01250.x 1:STN:280:DyaE2M7hsFWrtw%3D%3D
2. O Fardal RS Turnbull 1986 A review of the literature on use of chlorhexidine in dentistry J Am Dent Assoc. 112 863 869 2940282 1:CAS:528:DyaL28XksFeqt7w%3D
3. P Axelsson J Lindhe 1987 Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man J Clin Periodontol. 14 205 212 3294914 10.1111/j.1600-051X.1987.tb00968.x 1:STN:280:DyaL2s3itlajsw%3D%3D (Pubitemid 17062145)
4. PK Sreenivasan E Gittins 2004 The effects of a chlorhexidine mouthrinse on culturable microorganisms of the tongue and saliva Microbiol Res. 159 365 370 15646383 10.1016/j.micres.2004.08.002 1:CAS:528:DC%2BD2MXitVKitbs%3D (Pubitemid 39568732)
5. J König V Storcks T Kocher K Bössmann H-C Plagmann 2002 Anti-plaque effect of tempered 0.2% chlorhexidine rinse: an in vivo study J Clin Periodont 29 207 210 10.1034/j.1600-051x.2002.290304.x (Pubitemid 41697854)
6. AJ McBain RG Bartolo CE Catrenich D Charbonneau RG Ledder P Gilbert 2003 Effects of a chlorhexidine gluconate-containing mouthwash on the vitality and antimicrobial susceptibility of in vitro oral bacterial ecosystems Appl Env Microbiol. 69 4770 4776 10.1128/AEM.69.8.4770-4776.2003 1:CAS:528: DC%2BD3sXmsFWrtL8%3D (Pubitemid 36992940)
7. LM Sreebny 2000 Saliva in health and disease: an appraisal and update Int Dent J. 50 140 161 10967766 1:STN:280:DC%2BD3M%2Fls1ajtA%3D%3D
8. Hughes L, Gehris A, Rohm and Haas Company-Buccal dissolution of active substances. US patent application 20030087457 A1; 2003.
9. Y Sudhakar K Kuotsu AK Bandyopadhyay 2006 Buccal bioadhesive drug delivery-A promising option for orally less efficient drugs J Control Release 114 15 40 16828915 10.1016/j.jconrel.2006.04.012 1:CAS:528:DC%2BD28XnsFCrtrw%3D (Pubitemid 44128620)
10. European Pharmacopeia. 6th ed. Strasbourgh: Council of Europe, European Directorate for the Quality of Medicines; 2007.
11. The United States Pharmacopoeia 31st ed. The National Formulary. 26th ed. Rockville: The United States Pharmacopoeial Convention Inc; 2007.
12. E Nicolaides M Symillides JB Dressman C Reppas 2001 Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration Pharm Res. 18 380 388 11442280 10.1023/A:1011071401306 1:CAS:528:DC%2BD3MXltVSktr0%3D (Pubitemid 32595828)
13. PM Belda JB Mielck 1998 The tabletting machine as an analytical instrument: consequences of uncertainties in punch force and punch separation data on some parameters describing the course of the tabletting process Eur J Pharm Biopharm. 46 381 395 9885312 10.1016/S0939-6411(98)00027-7 1:CAS:528:DyaK1MXks1eqsA%3D%3D (Pubitemid 29057687)
14. PM Belda JB Mielck 2006 Considerations about the theoretically expected crushing strength of tablets from binary powder mixtures: double layer tablets versus arithmetic additivity rule Eur J Pharm Biopharm. 64 343 350 16914296 10.1016/j.ejpb.2006.06.007 1:CAS:528:DC%2BD28XhtFSrur3K (Pubitemid 44585213)
15. International Pharmacopeia. 4th ed. Geneve: WHO; 2008.
16. Frontini R. Dissertation-TOCCATA vers. 9/91. Hamburg: University of Hamburg; 1991.
17. SH Neau MA Howard JS Claudius DR Howard 1999 The effect of the aqueous solubility of xanthine derivatives on the release mechanism from ethylcellulose matrix tablets Int J Pharm. 179 97 105 10053206 10.1016/S0378-5173(98)00391-3 1:CAS:528:DyaK1MXhsVensLg%3D (Pubitemid 29115064)
18. JG Wagner 1970 Rate of dissolution in vitro and in vivo Drug Intel Clin Pharm. 4 132 137 1:CAS:528:DyaE3cXkslGitLo%3D
19. RJ Withey 1971 The kinetics of dissolution for a non-disintegrating standard substrate J Pharm Pharmacol. 23 573 582 4397739 1:CAS:528: DyaE3MXkvFWhurc%3D
20. JM Aceves R Cruz E Hernandez 2000 Preparation and characterization of Furosemide-Eudragit controlled release systems Int J Pharm. 195 45 53 10675682 10.1016/S0378-5173(99)00303-8 1:CAS:528:DC%2BD3cXhtV2hs7k%3D (Pubitemid 30089489)
21. Y Machida H Masuda N Fujiyama S Ito M Iwata T Nagai 1979 Preparation and phase II examination of topical dosage form for treatment of carcinoma coil containing bleomycin with hydroxypropyl cellulose Chem. Pharm. Bull. 27 93 100 85501 1:CAS:528:DyaE1MXhslCls7o%3D
22. N Fotaki M Symillides C Reppas 2005 In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis Eur J Pharm Sci. 24 115 122 15626585 10.1016/j.ejps.2004.10.003 1:CAS:528:DC%2BD2MXjtlCn (Pubitemid 40051294)
23. M Pernarowski W Woo RD Searl 1968 Continuos flow apparatus for the determination of the dissolution characteristics of tablets and capsules J Pharm Sci. 57 1419 1421 5677352 10.1002/jps.2600570832 1:CAS:528:DyaF1cXks1Wmsb0%3D
24. Deutscher Arzneimittel-Codex, Deutscher Apotheker Verlag, Stuttgart; 1984.
25. E Beyssac J Lavigne 2005 Dissolution study of active pharmaceutical ingredients using the flow through apparatus USP 4 Dissol Technol. 5 23 25
26. AE Collins PB Deasy 1990 Bioadhesive lozenge for the improved delivery of cetylpirydynium chloride J Pharm Sci. 79 116 119 2324958 10.1002/jps.2600790208 1:CAS:528:DyaK3cXitVCls74%3D
27. R Chandrasekhar Z Hassan F AlHusban AM Smith AR Mohammed 2009 The role of formulation excipients in the development of lyophilized fast disintegrating tablets Eur J Pharm Biopharm. 72 119 129 19073253 10.1016/j.ejpb.2008.11.011 1:CAS:528:DC%2BD1MXjvVOqsbw%3D